Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
PTCT | PTC THERAPEUTICS, INC. | Director | $554K | -$765K | -58% | May 22, 2024 |
NXGL, NXGLW | NEXGEL, INC. | Director | $258K | +$25K | +10.7% | Sep 13, 2024 |
NEXI | NexImmune, Inc. | Executive VP of Research & Dev | Apr 5, 2022 | |||
SNGX | SOLIGENIX, INC. | Director | Dec 15, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|